Cytovation Identifies Unique Peptide For Treatment Of Cutaneous Warts

Emerging Company Profile: After an early quiet period, Norway's Cytovation has raised funds locally in the past year to support initial clinical studies of a potential first-in-class viralytic and oncolytic peptide.

Emerging Company Profile Regular column feature image Version 2

More from Start-Ups & SMEs

More from Business